4XS.F - Express Scripts Holding Company

Frankfurt - Frankfurt Delayed Price. Currency in EUR
51.803
-0.234 (-0.450%)
As of 8:02AM CET. Market open.
Stock chart is not supported by your current browser
Previous Close52.037
Open51.803
Bid51.778 x 50000
Ask52.169 x 50000
Day's Range51.803 - 51.803
52 Week Range47.977 - 73.624
Volume55
Avg. Volume58
Market Cap29.919B
Beta0.98
PE Ratio (TTM)8.99
EPS (TTM)5.762
Earnings DateN/A
Forward Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2003-11-12
1y Target EstN/A
  • Better Buy: CVS Health Corp. vs. Express Scripts Holding Company
    Motley Fool54 minutes ago

    Better Buy: CVS Health Corp. vs. Express Scripts Holding Company

    Both major healthcare stocks have fallen to what looks like bargain territory. Find out which one's the best pick right now.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit2 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding ESRX totaled $963 million.

  • Barrons.com7 days ago

    [$$] Two Lawsuits Hit Express Scripts Unit on Pricing

    A securities filing made Tuesday by Express Scripts Holdings (ESRX) disclosed two large lawsuits that claim its subsidiary United Biosource helped drugmakers market their products in violation of antitrust and anti-kickback laws. The allegations in those suits touch on issues that Barron’s covered in a 2015 story that described how UBC’s contracts to promote drugmakers’ high-priced products seemed to conflict with the mission of its pharmacy benefit management parent: that is, to keep a lid on America’s drug bills (“Express Scripts Unit’s Connection to High Priced Specialty Drugs,” November 21, 2015). Other companies also named as defendants in the two suits were Eli Lilly & Co. (LLY) and Mallinckrodt PLC (MNK), as well as the Covance unit of Laboratory Corp. of America Holdings (LH).

  • Express Scripts signs a deal with start-up Propeller Health as it ups investment in digital health
    CNBC7 days ago

    Express Scripts signs a deal with start-up Propeller Health as it ups investment in digital health

    Express Scripts, the largest pharmacy benefits manager, is teaming up with a start-up that specializes in COPD and asthma.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit7 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding ESRX is favorable, with net inflows of $16.14 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

  • Forbes9 days ago

    Neal Sample's Journey From CIO To Divisional President At Amex To CIO Of Express Scripts

    Express Scripts CIO Neal Sample has extraordinary breadth and depth of experience. He has a PhD in computer science from Stanford, and can dig deep into the technical weeds, has run businesses in addition to being a CIO, and has worked for digital natives (Yahoo and eBay) and behemoths alike.

  • MarketWatch22 days ago

    CVS-Aetna deal won’t necessarily make drugs cheaper — and could even raise prices

    Savings on medical and pharmacy costs are a major aspect of the deal, but this Wall Street analyst doesn’t see it happening.

  • Express Scripts (ESRX) in Focus: Stock Moves 5.5% Higher
    Zacks23 days ago

    Express Scripts (ESRX) in Focus: Stock Moves 5.5% Higher

    Express Scripts (ESRX) saw its shares rise over 5% on the day.

  • Reuters24 days ago

    CVS bid for Aetna: A $66 billion bet on cutting drug costs

    The proposed merger between U.S. pharmacy operator CVS Health Corp and No. 3 health insurer Aetna Inc represents a $66 billion bet that insurers can drive down high U.S. drug prices by cutting out the middleman. The move is the most expensive effort to date that would enable a national health insurer to take back full control of prescription medicines for their customers by negotiating prices with pharmaceutical manufacturers and setting customer out-of-pocket costs for each drug. CVS, one of the largest U.S. pharmacy benefits managers, has offered to buy No. 3 health insurer Aetna for more than $200 per share, sources said on Thursday.

  • CVS-Aetna Deal Could Mean End of Era in How Drugs Are Paid For
    Bloomberg26 days ago

    CVS-Aetna Deal Could Mean End of Era in How Drugs Are Paid For

    The potential acquisition of Aetna Inc. by CVS Health Corp. would create an integrated health-care behemoth and put huge pressure on standalone players such as Express Scripts Holding Co. and Walgreens ...

  • Barrons.com26 days ago

    [$$] Express Scripts Buy Looks Healthy

    Maxim Group We would continue to be buyers of Express Scripts following its conference call on mixed third-quarter results. Express Scripts (ESRX) provided additional detail on the pending acquisition of eviCore and on its previously announced enterprise value initiative.

  • Express Scripts (ESRX) Q3 2017 Earnings Conference Call Transcript
    Motley Fool27 days ago

    Express Scripts (ESRX) Q3 2017 Earnings Conference Call Transcript

    ESRX earnings call for the period ending September 30, 2017.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit27 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last month, growth of ETFs holding ESRX is favorable, with net inflows of $14.03 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

  • The Wall Street Journal27 days ago

    [$$] Express Scripts Only Looks Cheap

    The pharmacy-benefits manager has a low valuation but that masks challenges including growth, regulation and competition.

  • Reuters28 days ago

    Express Scripts shrugs off Amazon threat in pharmacy benefits

    Express Scripts, the biggest pharmacy benefit manager (PBM)in the United States, along with drug distributors have been under pressure by the rumored entry of Amazon into the prescription drug market. "I feel very confident we'll stand well against an entry in the PBM space, be it Amazon or anybody," Express Scripts Chief Executive Timothy Wentworth said on a conference call. Express Scripts, which reported lower-than-expected quarterly revenue on Tuesday, named James Havel as the chief financial officer and said it aims to retain more customers in 2018.

  • Reuters28 days ago

    Express Scripts shrugs off Amazon threat in pharmacy benefits

    Express Scripts, the biggest pharmacy benefit manager (PBM)in the United States, along with drug distributors have been under pressure by the rumored entry of Amazon into the prescription drug market. "I feel very confident we'll stand well against an entry in the PBM space, be it Amazon or anybody," Express Scripts Chief Executive Timothy Wentworth said on a conference call. Express Scripts, which reported lower-than-expected quarterly revenue on Tuesday, named James Havel as the chief financial officer and said it aims to retain more customers in 2018.

  • Morningstar28 days ago

    Express Scripts Raises Its Outlook for Selling Season

    We are reiterating our $89 fair value estimate and wide moat rating for the healthcare services player.

  • MarketWatch28 days ago

    3 reasons Express Scripts could be headed for trouble

    Threatened by Amazon and having lost its biggest client, Express Scripts stock has dropped nearly 18% in three months.

  • Express Scripts (ESRX) Q3 Earnings In Line, FY17 View Up
    Zacks28 days ago

    Express Scripts (ESRX) Q3 Earnings In Line, FY17 View Up

    Express Scripts Holding Company (ESRX) posted robust first-quarter numbers driven by operational cost improvement backed by focus on technology, digital tools, home delivery and specialty services.

  • Reuters29 days ago

    Express Scripts CFO Eric Slusser resigns

    (Reuters) - Express Scripts Holding Co (ESRX.O) said on Tuesday James Havel would succeed Eric Slusser as the chief financial officer, effective Oct. 25, and the pharmacy benefit manager aimed to retain ...

  • Reuters29 days ago

    Express Scripts CFO Eric Slusser resigns

    Express Scripts Holding Co said on Tuesday James Havel would succeed Eric Slusser as the chief financial officer, effective Oct. 25, and the pharmacy benefit manager aimed to retain more customers in 2018. ...

  • The Wall Street Journal29 days ago

    [$$] Express Scripts Names Havel as Finance Chief

    Pharmacy-benefit manager Express Scripts Holding Co. has named veteran finance executive James Havel to serve as its finance chief, returning him to a role he held on an interim basis two years ago.

  • Associated Press29 days ago

    Express Scripts meets 3Q profit forecasts

    The St. Louis-based company said it had profit of $1.46 per share. Earnings, adjusted for one-time gains and costs, were $1.90 per share. The results met Wall Street expectations. The average estimate ...

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit29 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding ESRX totaled $41.02 billion.

  • Express Scripts raises full year 2017 guidance after mixe...
    CNBC Videos29 days ago

    Express Scripts raises full year 2017 guidance after mixe...

    CNBC's Bertha Coombs reports on the quarterly earnings report for Express Scripts.